Prolonged in vivo expression and anti-tumor response of DNA-based anti-HER2 antibodies

Antibody gene transfer presents an appealing alternative to conventional antibody protein therapy. This pre-clinical study evaluates the impact of various parameters on the pharmacokinetics and efficacy of in vivo expressed DNA-based anti-HER2 monoclonal antibodies (mAbs), newly engineered and deliv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollevoet, Kevin, De Smidt, Elien, Geukens, Nick, Declerck, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862603/
https://www.ncbi.nlm.nih.gov/pubmed/29568382
http://dx.doi.org/10.18632/oncotarget.24426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862603/
https://www.ncbi.nlm.nih.gov/pubmed/29568382
http://dx.doi.org/10.18632/oncotarget.24426

Ejemplares similares